Leading academic centers, research institutes, contract research organizations and pharmaceutical companies worldwide rely on MediBeacon technology. More >>
Measurement of GFR is widely accepted as the best indicator of kidney function. A clinically practical and accurate real-time point of care methodology holds promise. More >>
Fluorescent agent angiography has the potential to aid in diagnosis and monitoring of vasculature leakage seen in Diabetic Retinopathy, Macular Degeneration and Retinal Vasculitis. More >>
Intraoperative identification of ureter or ureteral injury is critical to prevent serious complications. Use of fluorescent agents could potentially aid in surgical visualization. More >>
Industry leaders including scientists and clinicians are behind fluorescence enabled technology that has the potential to impact global health. More >>
Let us know how we can continue the conversation. More >>
IN DISCOVERY
Advances in fluorescent technology brought to light.
Fluorescent tracer agent-based monitoring systems hold promise in a range of potential medical applications.
MediBeacon is continuing to explore additional uses of novel fluorescent tracer agents and their transdermal detection with the goal of improving patient care.*
Follow the progress: Sign up today to receive notifications of milestones, news and updates on MediBeacon fluorescent technology.